Last reviewed · How we verify

NCT05538936

The Effect of Spa and Massage on Babies on Colic Symptoms

Completed NA Last updated 18 December 2025
What this trial tests

NA trial testing Baby SPA in Infantile Colic in 72 participants. Completed in 11 December 2023.

Timeline
1 August 2022
Primary endpoint
30 January 2023
11 December 2023

Quick facts

Lead sponsorYuzuncu Yil University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment72
Start date1 August 2022
Primary completion30 January 2023
Estimated completion11 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yuzuncu Yil University

Who can join

Adults 40 Days to 4 Months, any sex, with Infantile Colic or Infantile Spasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although various complementary health approaches have been examined to alleviate colic symptoms, there seems to be a limited number of studies on SPA and massage applications. For this reason, the study was planned to determine the effectiveness of nurses' baby SPA and massage practices in reducing colic symptoms in babies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of SPA and massage applied on babies on colic symptoms: A randomized controlled trial.
    Akdogan R, Yildiz S. · · 2025 · cited 1× · PMID 40253272 · DOI 10.1016/j.pedn.2025.04.008

Verify or expand the search:

Other recruiting trials for Infantile Colic

Currently open trials in the same condition.

Other Yuzuncu Yil University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05538936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing